Bioinformatics Analysis of UFGT Gene from Several Economic Plants
Fu Haihui,Xin Peiyao,Xu Yulan,Liu Yan,Wei Yuanjiao,Dong Jiao,Cao Youlong,Zhou Jun
DOI: https://doi.org/10.3969/gab.030.000092
2011-01-01
Genomics and Applied Biology
Abstract:In this paper, the nucleic acid sequences and amino acid sequences of flavonoid-3-O-glucosyltransferas from six species such as Vitis vinifera, Zea mays, Oryza sativa, Fragaria×ananassa, Arabidopsis thaliana and Malus domestica, were analyzed by bioinformatics tools. Several parameters of these sequences logined in GeneBank, including sequences composition, physicochemical property, leader peptide, topological structure of transmembrane regions, hydrophobicity or hydrophilicity, secondary structures, functional domains and protein structures, were predicted. Phylogenetic tree was reconstructed for the flavonoid-3-O-glucosy-ltransferase protein family. UFGT genes contain only one exon in most of these plants, but two exons in V. vinifera. Abundant with Leu, Ala, Gly, Val and Ser amino acids, most of these UFGT proteins are structural stable except for those from V. vinifera and apple. In all these UFGT protein, evident hydrophobic or hydrophilic domain, signal peptide, transmembrane region and coiled-coil domain were predicted; and similar ratio in secondary structure composition made from α-helixes, sheets and random coils were detected. All these proteins have UDPGT, COG1819, MGT conserved domains. The 3-dimensional structures were constructed through rough homology modeling method successfully for most of these proteins but not for the one from Arabidopsis. In evolutionary analysis all these UFGT proteins were divided into five groups, among which were three major ones and two single one that from Gossypium hirsutum L. and Camptotheca acuminate respectively. This work would provide a basis for the function determination of this protein in color variance of different plant organs, such as flowers, fruits and leaves, and develop biological macromolecule structual simulation and molecular drug design.